GILD Stock | News | Quote | Stock Forum | Sunday, November 10,

New Post Public Reply Private Reply Replies (0) Message Board

Nov 10, 2013 at 1:56 PM

$GILD Gilead Sciences, Inc. GILD Company Overview

Stock Message Board http://investorshangout.com/search?q=GILD&...mp;yt1=Go!

Last Updated: Sunday, November 10, 2013 1:56:40 PM

Gilead Sciences, Inc. GILD Current Price and Quotes
Last Price 67.37
Previous Close 65.63 Open 66.50
Daily Range 67.58 - 66.25 52wk Range 73.20 - 32.07
Volume 12,507,053 Dividend N/A
Average Vol (3m) 7,799,396 Yield N/A
Gilead Sciences, Inc. GILD
Company Information

333 Lakeside Drive
Foster City, CA 94404

Website: http://www.gilead.com
Phone: 650-574-3000

Gilead Sciences, Inc. GILD
Not Available

Gilead Sciences, Inc. GILD
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Latest Report Sep 30, 2013 10-Q
CIK 0000882095
Fiscal Year End 12/31
OTC Marketplace Not Available
Profile Data

SIC - Industry Classification Not Available
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Gilead Sciences, Inc. GILD
GILD Security Details

Share Structure

Market Value1 $102,719,056,611 a/o Nov 08, 2013
Shares Outstanding 1,533,349,106 a/o Oct 18, 2013
Float Not Available
Authorized Shares Not Available
Par Value 0.001
Shareholders

Shareholders of Record 486 a/o Feb 27, 2009
Corporate Actions

Ex. Date Record Date Pay Date
Dividend (0.00) Jan 28, 2013 Jan 07, 2013 Jan 25, 2013
Dividend (0.00) Jun 25, 2007 May 24, 2007 Jun 22, 2007
Dividend (0.00) Sep 07, 2004 Aug 12, 2004 Sep 03, 2004
Security Notes

Capital Change=shs increased by 2 for 1 split. Ex-date=03/08/2002. Rec date=02/14/2002. Pay date=03/07/2002.
Latest Addt'l Issue=2-96 4,000,000 shs at $37.75 by Robertson, Stephens & Co. et al.
New Issue=1-92 5,000,000 shs at $15 by Robertson, Stephens & Co., et al.
Capital Change=shs increased by 2 for 1 split. Ex-date=02/22/2001. Rec date=02/02/2001. Pay date=02/21/2001.
Capital Change=shs increased by 2 for 1 split. Ex-date=09/07/2004. Rec date=08/12/2004. Pay date=09/03/2004.
Capital Change=shs increased by 2 for 1 split Ex-date=06/25/2007. Rec date=05/24/2007. Pay date=06/22/2007.
Capital Change=shs increased by 2 for 1 split. Ex-date=01/28/2013. Rec date=01/07/2013. Pay date=01/25/2013.
Short Selling Data

Short Interest 19,440,457 (-7.51%)
Nov 30, 2010
Significant Failures to Deliver No
Transfer Agent(s)

BNYMellon Shareowner Services

Gilead Sciences, Inc. GILD Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 9,702,517 8,385,385 7,949,420 7,011,383
Cost of Revenue 2,471,363 2,124,410 1,869,876 1,595,558
Gross Profit 7,231,154 6,260,975 6,079,544 5,415,825
Operating Expenses

Research and Development 1,759,945 1,229,151 1,072,930 939,918
Sales, General and Admin. 1,461,034 1,241,983 1,044,392 946,686
Non-Recurring Items - - - -
Other - - - -
Operating Income 4,010,175 3,789,841 3,962,222 3,529,221
Income From Continuing Operations

Add'l Income/Expense Items (37,279) 66,581 60,287 42,397
Earnings Before Interest and Tax 3,972,896 3,856,422 4,022,509 3,571,618
Interest Expense 360,916 205,418 108,961 69,662
Earnings Before Tax 3,611,980 3,651,004 3,913,548 3,501,956
Income Tax 1,038,381 861,945 1,023,799 876,364
Minority Interest (17,967) (14,578) (11,508) (10,163)
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 2,591,566 2,803,637 2,901,257 2,635,755
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 2,591,566 2,803,637 2,901,257 2,635,755
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 2,591,566 2,803,637 2,901,257 2,635,755

Gilead Sciences, Inc. GILD Recent News

Nov 8, 2013 S.F. Voters Repudiate Gilead, Other Pharma's Greed with Prop. D Victory
Nov 7, 2013 Gilead to Present Data on Oncology Pipeline at American Society of Hematology Annual Meeting
Nov 6, 2013 The Zacks Analyst Blog Highlights: Actelion, Bayer, Pfizer, Gilead Sciences and Honeywell International
Nov 6, 2013 Clinical Trial Data, New Publications, Promotions, Financial Results and FDA Acknowledgements - Research Report on Gilead, Amgen, ACADIA Pharmaceuticals, ViroPharma, and MannKind
Nov 5, 2013 The Zacks Analyst Blog Highlights: Fossil, Bristol-Myers Squibb, Gilead Sciences, Actelion and Johnson & Johnson
Nov 4, 2013 Under AAAResearchReports.com Microscope: Gilead Sciences Inc., NPS Pharma Inc., Halozyme Therapeutics Inc., and InterMune Inc.
Nov 4, 2013 Quarterly Financial Reports, Clinical Study Results, and R&D Events for the Investment Community - Research Report on Gilead Sciences, Clovis, Theravance, Charles River, and Acorda
Nov 2, 2013 Gilead Announces New Sustained Viral Response Data for Sofosbuvir-Based Regimens in Genotype 3-Infected Hepatitis C Patients
Nov 2, 2013 Gilead Announces Phase 3 Results for an All-Oral, Sofosbuvir-Based Regimen for the Treatment of Hepatitis C in Patients Co-Infected With HIV
Nov 2, 2013 Gilead Announces Phase 2 Results for Sofosbuvir-Based Regimens in Hepatitis C Patients Before and After Liver Transplantation

1
2
3
4
5
6
next >

GILD Gilead Sciences, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=GILD&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/GILD/quote
Stock Chart http://www.otcmarkets.com/stock/GILD/chart
Company Info http://www.otcmarkets.com/stock/GILD/company-info
Recent News http://www.otcmarkets.com/stock/GILD/news
Financials http://www.otcmarkets.com/stock/GILD/financials
Filings and Disclosure http://www.otcmarkets.com/stock/GILD/filings
Short Sales http://www.otcmarkets.com/stock/GILD/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/GILD/insider-transactions
Research Reports http://www.otcmarkets.com/stock/GILD/research
Summary http://finance.yahoo.com/q?s=GILD
Historical Prices http://finance.yahoo.com/q/hp?s=GILD+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=GILD
Basic Chart http://finance.yahoo.com/q/bc?s=GILD+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=GILD+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=GILD+Headlines
Press Releases http://finance.yahoo.com/q/p?s=GILD+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=GILD+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=GILD+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=GILD+Industry
Major Holders http://finance.yahoo.com/q/mh?s=GILD+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=GILD+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=GILD+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=GILD
Balance Sheet http://finance.yahoo.com/q/bs?s=GILD
Cash Flow http://finance.yahoo.com/q/cf?s=GILD+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/GILD
Market Watch http://www.marketwatch.com/investing/stock/GILD
Bloomberg http://www.bloomberg.com/quote/GILD:US
Morningstar http://quotes.morningstar.com/stock/s?t=GILD
Bussinessweek http://investing.businessweek.com/research/st...icker=GILD
Barchart http://www.barchart.com/quotes/stocks/GILD
OTC Short Report http://otcshortreport.com/index.php?index=GILD
Investopedia http://www.investopedia.com/markets/stocks/GILD/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ImmVira's Bladder Cancer Trials: Promising Data Revealed

Tackling Bladder Cancer with Innovation In a world where every budding biotech claims they're on the cusp of revolutionizing cancer treatment, ImmVira's recent data on their oncolytic immunotherapy, MVR-T3011, stands out like a bright flash in a murky market. Presented at the prestigious European Society for Medical Oncology (ESMO) Congress 2026 in Suzhou, these updates...

CobbleStone Partners with Hatch: Impact on CLM Success

Seeing CobbleStone Software team up with Hatch Advisory feels like stumbling across an old pal leading a promising venture down the innovation road. This partnership isn't just another handshaking ceremony—it's a real shift for the tech-adoption space, especially in the contract lifecycle management (CLM) domain, where CobbleStone already has quite the footprint....

Molly Carlson Dives Into History on Icebergs

Turning Icebergs Into Diving Platforms: Molly Carlson's Bold Leap You ever hear about someone diving off an iceberg? I hadn't either until Molly Carlson decided to take the plunge—literally. Bringing guts to an icy landscape wasn't part of most people's adventure checklist, but for her, it was a shakeup of epic proportions. On June 11, 2026, out at Twillingate,...

World Treadmill Championship: A New Run Begins

A Run Like No Other I’ll bet you’ve heard it all when it comes to races—winding city marathons, grueling ultras with rough terrain, and everything in between. But a world championship on treadmills? Now that's a fresh spin! October 23rd, 2026 is when the RUN X™ World Treadmill Championship kicks off, stretching out across the planet in 400 fitness centres...

AULUMU Unveils High-Design ADuo iPhone Case

A Space-Aged Look for Everyday Use In the gadget world, appearances matter but durability matters more. So AULUMU rolls out the ADuo Particle Aramid Fiber Case for iPhone Duo, making a bold claim in the realm of tech accessories. The Backbone: Aramid Fiber Aramid fiber isn't your run-of-the-mill material. We're talking 1500D quality here—strong but feather-light, a...

Scage Future's ADS Ratio Change: What's Next?

A New Era for Scage Future's ADS Holders You don't wake up every day to catch a one-for-fifteen reverse ADS split staring you right in the face, but for Scage Future's shareholders, that's exactly what's happening. The company, a pretty big deal in the zero-emission heavy-duty vehicle scene, made waves by announcing they're tinkering with their ADS ratio. You see, the...

VoxNexus Debuts On-Device AI: A Game-Changer for Languages

VoxNexus Changes the Game with VoxEdge Here's the rub with tech: it often feels like it's only for the folks who already have a leg up. VoxNexus just flipped the script with its new product, VoxEdge, an on-device voice stack that's making waves by breaking language barriers in the ever-evolving AI world. This move might just shift the landscape of voice artificial...

WOLFX Super App Surges with 300% Growth Post-Launch

A Fast-Paced Entry into the College Scene College life isn’t getting any easier, but the WOLFX app is blazing a trail through U.S. campuses, promising to mend some of the chaos students deal with daily. It's barely taken a breath since launching just a month ago, already knitting itself into the routine of students from 104 universities in 130 cities across America -...

Community Heritage Adopts Stock Repurchase Program

Community Heritage's Bold Move: A Stock Repurchase Well, here's a curveball in the financial game: Community Heritage Financial, Inc., the brain behind Middletown Valley Bank, recently threw its hat into the stock repurchase ring. This Maryland-rooted outfit announced on October 22, 2026, that its Board of Directors approved a program permitting the buyback of up to...

Fontainebleau Las Vegas is Set to Thrill Race Fans

Revving Up for the 2026 Race Weekend Fontainebleau Las Vegas is shifting into high gear to host a spectacular 2026 Race Weekend. The luxury resort on the Strip is gearing up for a whirlwind of activities and events from November 19 to 21, ensuring that race fans will find themselves knee-deep in excitement and extravagance. Expect iconic car displays, exclusive team...